NEW YORK, Aug 29 – Oxagen of Abingdon, UK, and Cerylid Biosciences of Melbourne, said Wednesday that they had agreed to collaborate to jointly study the genetic basis of endometriosis. 

Oxagen and Cerylid are planning to look for genes and SNPs that lead to endometriosis and to eventually find targets that will lead to new diagnostics and treatments for the disease, which is estimated to affect as many as 10 percent of women of reproductive age, the companies said. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.